Cyclopentolatum [INN-Latin] en es it fr

Cyclopentolatum [INN-Latin] Brand names, Cyclopentolatum [INN-Latin] Analogs

Cyclopentolatum [INN-Latin] Brand Names Mixture

  • No information avaliable

Cyclopentolatum [INN-Latin] Chemical_Formula


Cyclopentolatum [INN-Latin] RX_link

No information avaliable

Cyclopentolatum [INN-Latin] fda sheet

Cyclopentolatum [INN-Latin] msds (material safety sheet)

Cyclopentolatum_[INN-Latin] MSDS

Cyclopentolatum [INN-Latin] Synthesis Reference

No information avaliable

Cyclopentolatum [INN-Latin] Molecular Weight

291.385 g/mol

Cyclopentolatum [INN-Latin] Melting Point

139 oC (hydrochloride salt)

Cyclopentolatum [INN-Latin] H2O Solubility

No information avaliable

Cyclopentolatum [INN-Latin] State


Cyclopentolatum [INN-Latin] LogP


Cyclopentolatum [INN-Latin] Dosage Forms

Ophthalmic solution (eye drops)

Cyclopentolatum [INN-Latin] Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Cyclopentolatum [INN-Latin] Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Cyclopentolatum [INN-Latin] Absorption

Absorbed following ophthalmic administration.

Cyclopentolatum [INN-Latin] side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Cyclopentolatum [INN-Latin] Patient Information

No information avaliable

Cyclopentolatum [INN-Latin] Organisms Affected

Humans and other mammals